Mitoxantrone prednisone prostate longevity

Ixabepilone, mitoxantrone, and prednisone for metastatic.

Screen reader users, click here to load entire article This page uses Java Script to progressively load the article content as a user scrolls.

Read sample content on Prostate Cancer

In the late 1980s and early 1990s it was generally considered that men diagnosed with metastatic (but still hormone sensitive) prostate cancer had an estimated survival of 18 to 36 months from the time of diagnosis — including their time on treatment with hormonal therapy.

Ixabepilone, <strong>mitoxantrone</strong>, and <strong>prednisone</strong> for metastatic.


This is a heterogeneous of patients that ranges from those with pathologiy detected locoregional nodal metastases at the time of radical prostatectomy to those with widespread systemic disease.

Prostate Cancer and Prostatic Diseases - The influence of.

uses cookies to improve performance by remembering your session ID when you navate from page to page.

Mitoxantrone prednisone prostate longevity:

Rating: 88 / 100

Overall: 97 Rates